e-learning
resources
Vienna 2009
Wednesday, 16.09.2009
Sustainability in treatment of COPD patients according to economics and quality of care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Smoking cessation compared to treatment of COPD and other smoking-related diseases using cost-effectiveness evidence
J. Dollerup, P. B. Poulsen, H. J. Randskov, K. Møller Pedersen (Ballerup, Odense, Denmark)
Source:
Annual Congress 2009 - Sustainability in treatment of COPD patients according to economics and quality of care
Session:
Sustainability in treatment of COPD patients according to economics and quality of care
Session type:
Oral Presentation
Number:
4647
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Dollerup, P. B. Poulsen, H. J. Randskov, K. Møller Pedersen (Ballerup, Odense, Denmark). Smoking cessation compared to treatment of COPD and other smoking-related diseases using cost-effectiveness evidence. Eur Respir J 2009; 34: Suppl. 53, 4647
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Smoking cessation strategies in patients with COPD
Source: Eur Respir J 2013; 41: 727-734
Year: 2013
The cost-effectiveness of antidepressants for smoking cessation in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 801s
Year: 2006
Comparison of effectiveness of varenicline and NRTs in smoking cessation in patients with chronic diseases
Source: Annual Congress 2008 - Smoking cessation and new tobacco uses
Year: 2008
Recommendations for smoking cessation treatment in respiratory patients
Source: Annual Congress 2007 - PG15 - Difficult-to-treat asthma: dealing with smoker patients
Year: 2007
Smoking cessation among COPD and asthma patients: burden vs. motivation
Source: International Congress 2018 – Tobacco use and cessation interventions in patients with respiratory, cardiovascular and mental health problems and other populations
Year: 2018
Long-term effectiveness and cost-effectiveness of smoking cessation interventions in patients with COPD
Source: Annual Congress 2010 - Smoking related disorders and smoking cessation
Year: 2010
COPD patients‘ response to smoking cessation
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
Smoking cessation guidelines in health and chronic diseases
Source: Annual Congress 2006 - PG20 - Smoking cessation in a respiratory medicine setting
Year: 2006
The costs of smoking and the economics of smoking cessation
Source: Eur Respir Mon; 2008: 42: 23–34
Year: 2008
Effectiveness of a smoking cessation programme for COPD (SMOCC) in routine general practice
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
Evidence for harm reduction in diseased smokers
Source: Annual Congress 2007 - Targeting smokers by reduction: the "snus" connection revisited
Year: 2007
Effectiveness of smoking cessation in patients with psychiatric disease
Source: Annual Congress 2012 - Tobacco comorbidity
Year: 2012
Smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit
Source: Guideline 2015
Year: 2015
Different types of medical intervention and the smoking cessation rate in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 107s
Year: 2006
Diagnosis of COPD combined with brief smoking cessation advice increases smoking cessation rate in comparison with those with normal lung function
Source: Eur Respir J 2005; 26: Suppl. 49, 288s
Year: 2005
The SMOKE study: 1 year evaluation of an intensive multi-component smoking cessation programme for COPD outpatients
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
Smoking cessation by hospitalization yields a high rate of smoke abstinence in COPD-patients
Source: Annual Congress 2007 - Smoking and COPD
Year: 2007
Smoking cessation in patients with respiratory diseases
Source: Annual Congress 2005 - Smoking cessation in respiratory diseases: methods and results
Year: 2005
Smoking cessation and COPD
Source: Eur Respir Rev 2013; 22: 37-43
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept